{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:21:40Z","timestamp":1772119300039,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,10,25]],"date-time":"2008-10-25T00:00:00Z","timestamp":1224892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Surg Int"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1007\/s00383-008-2260-3","type":"journal-article","created":{"date-parts":[[2008,10,24]],"date-time":"2008-10-24T11:10:34Z","timestamp":1224846634000},"page":"19-23","source":"Crossref","is-referenced-by-count":23,"title":["Botulinum toxin in paediatric urology: a systematic literature review"],"prefix":"10.1007","volume":"25","author":[{"given":"Ranan","family":"DasGupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feilim Liam","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,25]]},"reference":[{"key":"2260_CR1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2165\/00003495-200666100-00001","volume":"66","author":"B Schurch","year":"2006","unstructured":"Schurch B (2006) Botulinum toxin for the management of bladder dysfunction. Drugs 66:1301\u20131318. doi: 10.2165\/00003495-200666100-00001","journal-title":"Drugs"},{"key":"2260_CR2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","volume":"139","author":"DD Dykstra","year":"1988","unstructured":"Dykstra DD, Sidi AA, Scott AB et al (1988) Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 139:919\u2013922","journal-title":"J Urol"},{"key":"2260_CR3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0022-5347(05)66438-5","volume":"165","author":"MW Phelan","year":"2001","unstructured":"Phelan MW, Franks M, Somogyi GT et al (2001) Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 165:1107\u20131110. doi: 10.1016\/S0022-5347(05)66438-5","journal-title":"J Urol"},{"key":"2260_CR4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.urology.2004.06.073","volume":"64","author":"CP Smith","year":"2004","unstructured":"Smith CP, Radziszewski P, Borkowski A et al (2004) Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 64:871\u2013875. doi: 10.1016\/j.urology.2004.06.073","journal-title":"Urology"},{"key":"2260_CR5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000020314","volume":"38","author":"D Zermann","year":"2000","unstructured":"Zermann D, Ishigooka M, Schubert J, Schmidt RA (2000) Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain? Eur Urol 38:393\u2013399. doi: 10.1159\/000020314","journal-title":"Eur Urol"},{"key":"2260_CR6","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.juro.2006.07.127","volume":"176","author":"YC Chuang","year":"2006","unstructured":"Chuang YC, Chancellor MB (2006) The application of botulinum toxin in the prostate. J Urol 176:2375\u20132382. doi: 10.1016\/j.juro.2006.07.127","journal-title":"J Urol"},{"key":"2260_CR7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.mou.0000172401.92761.86","volume":"15","author":"B Schurch","year":"2005","unstructured":"Schurch B, Corcos J (2005) Botulinum toxin injections for paediatric incontinence. Curr Opin Urol 15:264\u2013267. doi: 10.1097\/01.mou.0000172401.92761.86","journal-title":"Curr Opin Urol"},{"key":"2260_CR8","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","volume":"96","author":"A Paiva de","year":"1999","unstructured":"de Paiva A, Meunier FA, Molgo J et al (1999) Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci USA 96:3200\u20133205. doi: 10.1073\/pnas.96.6.3200","journal-title":"Proc Natl Acad Sci USA"},{"key":"2260_CR9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"A Apostolidis","year":"2006","unstructured":"Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49:644\u2013650. doi: 10.1016\/j.eururo.2005.12.010","journal-title":"Eur Urol"},{"key":"2260_CR10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1464-410X.2003.04722.x","volume":"93","author":"CM Brady","year":"2004","unstructured":"Brady CM, Apostolidis A, Harper M et al (2004) Parallel changes in bladder suburothelial vanilloid receptor TRPV1 (VR1) and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity (NDO) following intravesical resiniferatoxin treatment. BJUI 93:770\u2013776. doi: 10.1111\/j.1464-410X.2003.04722.x","journal-title":"BJUI"},{"key":"2260_CR11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","volume":"174","author":"A Apostolidis","year":"2005","unstructured":"Apostolidis A, Popat RB, Yiangou Y et al (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibres following intra-detrusor injections of Botulinum toxin for human detrusor overactivity. J Urol 174:977\u2013983. doi: 10.1097\/01.ju.0000169481.42259.54","journal-title":"J Urol"},{"key":"2260_CR12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","volume":"45","author":"M Khera","year":"2004","unstructured":"Khera M, Somogyi GT, Kiss S et al (2004) Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 45:987\u2013993. doi: 10.1016\/j.neuint.2004.06.001","journal-title":"Neurochem Int"},{"key":"2260_CR13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1464-410X.2003.03802.x","volume":"91","author":"OJ Wiseman","year":"2003","unstructured":"Wiseman OJ, Fowler CJ, Landon DN (2003) The role of the human bladder lamina propria myofibroblast. BJUI 91:89\u201393. doi: 10.1046\/j.1464-410X.2003.03802.x","journal-title":"BJUI"},{"key":"2260_CR14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1464-410X.2006.06255.x","volume":"98","author":"M Lagou","year":"2006","unstructured":"Lagou M, Drake MJ, Markerink-van Ittersum M et al (2006) Interstitial cells and phasic activity in the isolated mouse bladder. BJUI 98:643\u2013650","journal-title":"BJUI"},{"key":"2260_CR15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0041-0101(99)00153-1","volume":"38","author":"MJ Welch","year":"2000","unstructured":"Welch MJ, Purkiss JR, Foster KA (2000) Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins. Toxicon 38:245\u2013258. doi: 10.1016\/S0041-0101(99)00153-1","journal-title":"Toxicon"},{"key":"2260_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","volume":"107","author":"M Cui","year":"2004","unstructured":"Cui M, Khanijou S, Rubino J, Aoki KR (2004) Subcutaneous adminstration of botulinum toxin A reduces formalin-induced pain. Pain 107:125\u2013133. doi: 10.1016\/j.pain.2003.10.008","journal-title":"Pain"},{"key":"2260_CR17","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.eururo.2007.08.052","volume":"52","author":"A Reitz","year":"2007","unstructured":"Reitz A, Denys P, Fermnanian C, Schurch B et al (2007) Do repeat intradetrusor botulinum toxin type A injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Eur Urol 52:1729\u20131735. doi: 10.1016\/j.eururo.2007.08.052","journal-title":"Eur Urol"},{"key":"2260_CR18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","volume":"164","author":"B Schurch","year":"2000","unstructured":"Schurch B, Stohrer M, Kramer G et al (2000) Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164:692\u2013697. doi: 10.1016\/S0022-5347(05)67283-7","journal-title":"J Urol"},{"key":"2260_CR19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A Reitz","year":"2004","unstructured":"Reitz A, Stohrer M, Kramer G et al (2004) European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 45:510\u2013515. doi: 10.1016\/j.eururo.2003.12.004","journal-title":"Eur Urol"},{"key":"2260_CR20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.ju.0000162035.73977.1c","volume":"174","author":"B Schurch","year":"2005","unstructured":"Schurch B, de Seze M, Denys P et al (2005) Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo-controlled 6-month study. J Urol 174:196\u2013200. doi: 10.1097\/01.ju.0000162035.73977.1c","journal-title":"J Urol"},{"key":"2260_CR21","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","volume":"177","author":"A Sahai","year":"2007","unstructured":"Sahai A, Khan MS, Dasgupta P (2007) Efficacy of botulinum toxin-A for treating detrusor overactivity: results from a single center, randomized, double-blind, placebo-controlled trial. J Urol 177:2231\u20132236. doi: 10.1016\/j.juro.2007.01.130","journal-title":"J Urol"},{"key":"2260_CR22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11934-007-0041-5","volume":"8","author":"DJ Unwala","year":"2007","unstructured":"Unwala DJ, Barboglio P, Gousse AE (2007) Repeated botulinum toxin injection for idiopathic overactive bladder: will chemodenervation become a long-term solution? Curr Urol Rep 8:419\u2013424. doi: 10.1007\/s11934-007-0041-5","journal-title":"Curr Urol Rep"},{"key":"2260_CR23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ncpuro0521","volume":"3","author":"HU Ahmed","year":"2006","unstructured":"Ahmed HU, Shergill IS, Arya M, Shah PJR (2006) Management of detrusor-external sphincter dyssynergia. Nat Clin Pract Urol 3:368\u2013380. doi: 10.1038\/ncpuro0521","journal-title":"Nat Clin Pract Urol"},{"key":"2260_CR24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.2003.04312.x","volume":"92","author":"M Harper","year":"2003","unstructured":"Harper M, Popat RB, DasGupta R et al (2003) A minimally invasive technique for outpatient local anaesthetic adminstration of intradetrusor botulinum toxin in intractable detrusor overactivity. BJUI 92:325\u2013326. doi: 10.1046\/j.1464-410X.2003.04312.x","journal-title":"BJUI"},{"key":"2260_CR25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","volume":"53","author":"G Karsenty","year":"2008","unstructured":"Karsenty G, Denys P, Amarenco G et al (2008) Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review. Eur Urol 53:275\u2013287. doi: 10.1016\/j.eururo.2007.10.013","journal-title":"Eur Urol"},{"key":"2260_CR26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-4295(01)01641-7","volume":"59","author":"H Schulte-Baukloh","year":"2002","unstructured":"Schulte-Baukloh H, Michael T, Schobert J et al (2002) Efficacy of botulinum A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 59:325\u2013327. doi: 10.1016\/S0090-4295(01)01641-7","journal-title":"Urology"},{"key":"2260_CR27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","volume":"44","author":"H Schulte-Baukloh","year":"2003","unstructured":"Schulte-Baukloh H, Michael T, St\u00fcrzebecher B et al (2003) Botulinum-a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder. Eur Urol 44:139\u2013143. doi: 10.1016\/S0302-2838(03)00136-2","journal-title":"Eur Urol"},{"key":"2260_CR28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.ju.0000108892.35041.2d","volume":"171","author":"M Riccabona","year":"2004","unstructured":"Riccabona M, Koen M, Schindler M et al (2004) Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171:845\u2013848. doi: 10.1097\/01.ju.0000108892.35041.2d","journal-title":"J Urol"},{"key":"2260_CR29","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0022-5347(05)00400-3","volume":"175","author":"W Altaweel","year":"2006","unstructured":"Altaweel W, Jednack R, Bilodeau C, Corcos J (2006) Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele. J Urol 175:1102\u20131105. doi: 10.1016\/S0022-5347(05)00400-3","journal-title":"J Urol"},{"key":"2260_CR30","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.urology.2006.05.056","volume":"68","author":"AM Kajbafzadeh","year":"2006","unstructured":"Kajbafzadeh AM, Moosavi S, Tajik P et al (2006) Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele. Urology 68:1091\u20131096. doi: 10.1016\/j.urology.2006.05.056","journal-title":"Urology"},{"key":"2260_CR31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.2007.06977.x","volume":"100","author":"M Akbar","year":"2007","unstructured":"Akbar M, Abel R, Seyler TM et al (2007) Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJUI 100:639\u2013645. doi: 10.1111\/j.1464-410X.2007.06977.x","journal-title":"BJUI"},{"key":"2260_CR32","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.juro.2007.08.032","volume":"178","author":"KF Neel","year":"2007","unstructured":"Neel KF, Soliman S, Salem M et al (2007) Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder. J Urol 178:2593\u20132598. doi: 10.1016\/j.juro.2007.08.032","journal-title":"J Urol"},{"key":"2260_CR33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2005.11.006","volume":"49","author":"V Kalsi","year":"2006","unstructured":"Kalsi V, Popat RB, Apostolidis A et al (2006) Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre. Eur Urol 49:519\u2013527. doi: 10.1016\/j.eururo.2005.11.006","journal-title":"Eur Urol"},{"key":"2260_CR34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0022-5347(06)00301-6","volume":"176","author":"P Hoebeke","year":"2006","unstructured":"Hoebeke P, De Caestecker K, Vande Walle J et al (2006) The effect of botulinum-A toxin in incontinent children with therapy resistant overactive detrusor. J Urol 176:328\u2013331. doi: 10.1016\/S0022-5347(06)00301-6","journal-title":"J Urol"},{"key":"2260_CR35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0022-5347(17)45077-4","volume":"136","author":"FJ Hinman","year":"1986","unstructured":"Hinman FJ (1986) Non-neurogenic neurogenic bladder (the Hinman syndrome)\u201415\u00a0years later. J Urol 136:769\u2013772","journal-title":"J Urol"},{"key":"2260_CR36","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.juro.2006.03.119","volume":"176","author":"I Mokhless","year":"2006","unstructured":"Mokhless I, Gaafar S, Fouda K et al (2006) Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder. J Urol 176:1767\u20131770. doi: 10.1016\/j.juro.2006.03.119","journal-title":"J Urol"},{"key":"2260_CR37","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0022-5347(06)00298-9","volume":"176","author":"ZI Radojicic","year":"2006","unstructured":"Radojicic ZI, Perovic SV, Milic NM (2006) Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin. J Urol 176:332\u2013336. doi: 10.1016\/S0022-5347(06)00298-9","journal-title":"J Urol"},{"key":"2260_CR38","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1016\/j.juro.2007.08.027","volume":"178","author":"V Petronijevic","year":"2007","unstructured":"Petronijevic V, Lazovic M, Vlajkovic M et al (2007) Botulinum toxin type A in combination with standard urotherapy for children with dysfunctional voiding. J Urol 178:2599\u20132602. doi: 10.1016\/j.juro.2007.08.027","journal-title":"J Urol"}],"container-title":["Pediatric Surgery International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-008-2260-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00383-008-2260-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00383-008-2260-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:52:12Z","timestamp":1559044332000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00383-008-2260-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,25]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["2260"],"URL":"https:\/\/doi.org\/10.1007\/s00383-008-2260-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718452416.793514369","asserted-by":"object"}]},"ISSN":["0179-0358","1437-9813"],"issn-type":[{"value":"0179-0358","type":"print"},{"value":"1437-9813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,25]]}}}